U.S. drugmaker Pfizer Inc said on Thursday its experimental gene therapy for the treatment of hemophilia B, a rare inherited blood disorder, met its main goal in a late-stage study.
Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geronsaid on Thursday its experimental gene therapy for the treatment of hemophilia B, a rare inherited blood disorder, met its main goal in a late-stage study.
Data from the study showed that a single dose of the therapy was superior to the current standard of care in helping reduce the bleeding rate in patients with moderately severe to severe forms of hemophilia B.Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, as opposed to current treatments, which focus on regular infusions of the protein.Spark Therapeutics unit in 2014 for a $20-million upfront payment.
Pfizer plans to discuss the late-stage data with regulatory authorities in Europe and the United States and share additional data for the experimental therapy at a scientific conference in early 2023. According to government data, the estimated prevalence of hemophilia in the United States is 12 cases per 100,000 males for hemophilia A and 3.7 cases per 100,000 males for hemophilia B., the U.S. health regulator approved the first gene therapy, CSL Ltd and uniQure's Hemgenix, to treat hemophilia B.
Pfizer is also testing other experimental gene therapies in late-stage trials as potential treatments for the bleeding disorder hemophilia A and muscular disorder Duchenne muscular dystrophy.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer’s hemophilia B treatment meets primary endpoint in Phase 3 studyPfizer Inc. said Thursday that a Phase 3 study of fidanacogene elaparvovec for the treatment of hemophilia B in adult males met its primary endpoint of...
Read more »
Pfizer ruling spotlights unresolved, basic issue in recent affirmative action casesThe constellation of conservative activists who have led a decades-long legal battle against affirmative action suffered a minor setback last week that nevertheless offers vital insight into the broader campaign.
Read more »
AMC Stock Price | AMC Entertainment Holdings Inc. Cl A Stock Quote (U.S.: NYSE) | MarketWatchAMC | Complete AMC Entertainment Holdings Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Read more »
Challenger, Gray & Christmas, Inc. Job Hotline Offering Free Career CounsellingA new job may be just a phone call away. Career consultants from coaching company Challenger, Gray & Christmas, Inc. are accepting free calls Tuesday and Wednesday. NBC 5’s Kye Martin reports.
Read more »
What to expect when New York's first recreational cannabis dispensary opens Thursday in ManahattanNew York's first adult recreational cannabis dispensary opens Thursday in Manhattan. We hear from the CEO about what to expect:
Read more »
Southwest Airlines Cancels More Flights Wednesday, Thursday | Weather.comSouthwest Airlines officials say weather delays from last week have backed up flights and staff. The U.S. Department of Transportation says the airline's rate of cancellations is 'unacceptable.' - Articles from The Weather Channel | weather.com
Read more »